Previous 1 2 3 4 5 Next
Early Drug Discovery Expected to Improve with First-of-its-Kind Mass Spectrometry Platform from Applied Biosystems/MDS ...
FOSTER CITY, Calif.----Applied Biosystems , an Applera Corporation business, and its joint venture partner, Sciex, a division of MDS Inc.'s Analytical Technologies business, , today announced plans to commercialize a first-of-its-kind mass spectrometry platform designed to help pharmaceutical companies accelerate the drug compound screening process. (Tue, 17 Apr 2007 11:00:00 GMT)
Nanogen Submits 510(K) for Cystic Fibrosis Genetic Assay and NanoChip(R) 400 System
SAN DIEGO----Nanogen, Inc. , developer of advanced diagnostic products, announced today that it has submitted the 510 to FDA for its Cystic Fibrosis Kit and NanoChip® 400 microarray system. (Tue, 17 Apr 2007 12:00:00 GMT)
Matritech to Report First Quarter 2007 Financial Results on May 1, 2007
NEWTON, Mass.----Matritech announced today that it will release its first quarter 2007 earnings results before market opening on May 1, 2007. The company has scheduled a conference call at 8:30 a.m. that day to discuss the results and provide a company update. (Tue, 17 Apr 2007 12:00:00 GMT)
Invitrogen Garners Six Life Science Industry Awards
CARLSBAD, Calif.----Invitrogen Corporation , a provider of essential life science technologies for disease research and drug discovery, today announced it was recognized by the life sciences industry at The Scientists' annual Life Science Industry Awards, winning in six categories. (Tue, 17 Apr 2007 12:00:00 GMT)
Affymetrix and NuGEN Announce Agreement to Co-market the NuGEN WT-Ovation(TM) FFPE System
SANTA CLARA, Calif. & SAN CARLOS, Calif.----Affymetrix Inc. and NuGEN Technologies Inc., a privately held company that develops and commercializes nucleic acid amplification and labeling systems for small and difficult samples, announced today their agreement to co-market a solution that enables researchers to access FFPE tissue samples derived from years of clinical studies previously ... (Tue, 17 Apr 2007 12:00:00 GMT)
Millennium Discovers Biomarkers Potentially Predictive of Response to VELCADE(R) (Bortezomib) for Injection
Findings published in the April 15th issue of Blood show that a team of researchers led by Millennium Pharmaceuticals, Inc. has discovered biomarkers which may lead to identifying multiple myeloma patients likely to respond to VELCADE. (Tue, 17 Apr 2007 12:05:00 GMT)
Former Puebloans close to Virginia Tech tragedy
As the deadliest shooting rampage in U.S. history unfolded Monday morning on the Virginia Tech campus, former Puebloan Don Mullins was in a university greenhouse doing routine research. "I was out of touch in terms of e-mail and wasn't aware of what had happened until about 10 a.m.," Mullins said in a telephone interview Monday afternoon from his home in Blacksburg, Va. Mullins is a ... (Tue, 17 Apr 2007 12:15:34 GMT)
Murdock challenges researchers
250 scientists converge on N.C. Research Campus during conference (Tue, 17 Apr 2007 12:25:30 GMT)
Biosite Announces Expiration of Hart-Scott-Rodino Waiting Period for Tender Offer With Beckman Coulter
Biosite Incorporated today announced that the waiting period required under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 expired without a request for additional information from the U.S. (Tue, 17 Apr 2007 12:30:00 GMT)
AVN944 Biomarker Study Identifies Gene Signatures Important for Patient Stratification
GERMANTOWN, Md., April 17 /PRNewswire-FirstCall/ -- Avalon Pharmaceuticals, Inc. , today announced the results of an AVN944 biomarker study that utilized Avalon's proprietary AvalonRx(R) technology to identify gene signatures that may be useful for patient stratification. (Tue, 17 Apr 2007 13:03:58 GMT)
Nanogen Asks FDA for Kit Approval
Nanogen Inc., which develops medical test products, said it asked the Food and Drug Administration to approve its cystic fibrosis test kit and the Nanochip 400 microarray system. (Tue, 17 Apr 2007 13:06:59 GMT)
17 April 2007
Los Angeles – April 17, 2007 –DiaGenic ASA today presented prototypes for its early diagnostic test for breast cancer at the American Association for Cancer Research’s special Late-Breaking sessions at the 2007 Annual Meeting. (Tue, 17 Apr 2007 13:31:12 GMT)
Millennium Discovers Biomarkers Potentially Predictive of Response to VELCADE(R) (Bortezomib) for Injection
CAMBRIDGE, Mass., April 17 /PRNewswire-FirstCall/ -- Findings published in the April 15th issue of Blood show that a team of researchers led by Millennium Pharmaceuticals, Inc. has discovered biomarkers which may lead to identifying multiple myeloma patients likely to respond to VELCADE. (Tue, 17 Apr 2007 14:03:27 GMT)
TFN NEWS BRIEFING: Pharmaceuticals and chemicals highlights to 15:40 BST
AffyMetrix inks NuGEN pact SANTA CLARA, Calif. (AP) - Affymetrix Inc., which makes products used to analyze genetic information, said Tuesday it is partnering with NuGEN Technologies Inc. to market a product allowing researchers to examine genes on archived tissue samples. (Tue, 17 Apr 2007 14:46:52 GMT)
Agilent Technologies Announces Clinical Data's Cogenics Division As Its First Certified Service Provider For miRNA ...
Agilent Technologies, Inc., and Cogenics, a division of Clinical Data, Inc., today announced that Cogenics is the first Certified Microarray Service Provider for Agilent's microRNA (miRNA) microarrays (Tue, 17 Apr 2007 14:48:28 GMT)
Western avian influenza genomes sequenced
A U.S.-led team of researchers has reported the first large-scale sequencing of the western genomes of the deadly avian influenza virus H5N1. (Tue, 17 Apr 2007 15:12:37 GMT)
(AFX UK Focus) 2007-04-17 15:55 GMT: TFN NEWS BRIEFING: Pharmaceuticals and chemicals highlights to 15:40 BST
2007-04-17 14:47:03 AffyMetrix inks NuGEN pact (Tue, 17 Apr 2007 15:14:02 GMT)
Biosite to Conduct First Quarter 2007 Results Conference Call
Biosite Incorporated announces the following webcast: (Tue, 17 Apr 2007 15:34:00 GMT)
Western avian influenza genomes sequenced
A U.S.-led team of researchers has reported the first large-scale sequencing of the western genomes of the deadly avian influenza virus H5N1. The study, led by Steven Salzberg of the University of Maryland, confirmed not only has the virus spread west (Tue, 17 Apr 2007 15:35:49 GMT)
Nanogen Submits 510(K) for Cystic Fibrosis Genetic Assay and NanoChip(R) 400 System
Nanogen, Inc. (Nasdaq:NGEN), developer of advanced diagnostic products, announced today that it has submitted the 510(K) to FDA for its Cystic Fibrosis Kit and NanoChip® 400 microarray system. (Tue, 17 Apr 2007 16:00:27 GMT)
Affymetrix and NuGEN Announce Agreement to Co-Market the NuGEN WT-Ovation(TM) FFPE System
Affymetrix Inc. (NASDAQ:AFFX) and NuGEN Technol (Tue, 17 Apr 2007 16:01:37 GMT)
Western avian influenza genomes sequenced
A U.S.-led team of researchers has reported the first large-scale sequencing of the western genomes of the deadly avian influenza virus H5N1.The study, led by Steven Salzberg of the University of Maryland, confirmed not only has the virus spread west from Asia, but two of the new western strains have independently combined, or reassorted, to create a new strain.The research involved 36 genomes of ... (Tue, 17 Apr 2007 16:09:26 GMT)
Genes and biomarkers that allow doctors to choose the right therapy for the right patient
LOS ANGELES -- Genetic and epigenetic variations ensure that no two people are exactly alike, and the same holds true for any two cancers. (Tue, 17 Apr 2007 16:38:01 GMT)
Researchers sequence western H5N1 virus genomes
In a paper in the May issue of Emerging Infectious Diseases, an international team of researchers report the first ever large-scale sequencing of western genomes of the deadly avian influenza virus, H5N1. (Tue, 17 Apr 2007 17:04:16 GMT)
Genes and Biomarkers That Allow Doctors to Choose the Right Therapy for the Right Patient
At the 2007 Annual Meeting of the American Association for Cancer Research, researchers present new biomarkers - and techniques for determining biomarkers - that could determine how an individual might respond to drug or radiation therapy. (Tue, 17 Apr 2007 17:20:29 GMT)
AACR, FDA and NCI Announce Cancer Biomarkers Collaborative at the AACR 2007 Annual Meeting
The American Association for Cancer Research, together with the Food and Drug Administration and National Cancer Institute, today announces the formation of the AACR-FDA-NCI Cancer Biomarkers Collaborative (CBC) to facilitate the use of validated biomarkers in clinical trials and ultimately in evidence-based oncology and cancer medicine. (Tue, 17 Apr 2007 17:20:39 GMT)
State envisions BT policy, to make it strategic priority sector
GUJARAT is all set to get a biotechnology (BT) policy aimed at giving fillip to the cutting-edge sector by focusing on incentives, human resource development, and infrastructure development. Likely to be announced by in-charge Minister for Science and Technology Anandiben Patel on Wednesday, the policy would put in place a framework aimed at leveraging Gujarat s existing entrepreneurial strengths ... (Tue, 17 Apr 2007 19:03:55 GMT)
Hybrigenics' Inecalcitol Shows High Level Of Tolerance
Hybrigenics announces today the first results from its Phase I clinical trial of inecalcitol, a synthetic analogue of vitamin D under development by Hybrigenics as a potential treatment for prostate cancer. Inecalcitol was administered orally in a double-blind randomized study against placebo on 36 healthy volunteers up to 80 micrograms. No side effects were observed. [click link for full article] (Tue, 17 Apr 2007 19:06:44 GMT)
UCSD Cancer Researchers Report Ability to Detect Cancer at Earliest, Curable Stage
SAN DIEGO----Researchers at the Moores Cancer Center at the University of California, San Diego report that they have developed a new method for detecting cancer very early in its development, when it consists of just a few cells. (Wed, 18 Apr 2007 00:24:00 GMT)
Daily Digest
The Daily Digest intends to help readers track major announcements made by and about companies on the San Diego Stock Exchange Index. The Daily Digest tracks announcements and SEC filings released from midnight until 4 p.m., or three hours after the stock markets close. To see how companies on the San Diego Stock Exchange Index performed, turn to Page 8A. (Wed, 18 Apr 2007 01:30:22 GMT)
Genes And Biomarkers That Allow Doctors To Choose The Right Therapy For The Right Patient
Genetic and epigenetic variations ensure that no two people are exactly alike, and the same holds true for any two cancers. Now, researchers have the tools and the knowledge to help predict how individuals will respond to cancer therapies, enabling them to create more effective therapies for individual cancers -- personalized medicine. (Wed, 18 Apr 2007 04:07:37 GMT)
Scientists present their own ideas for research campus
CHARLOTTE - Researchers gathered at UNC Charlotte Tuesday gave recommendations for the vision of the North Carolina Research Campus. (Wed, 18 Apr 2007 04:26:03 GMT)
UCSD Cancer Researchers Report Ability to Detect Cancer at Earliest, Curable Stage
Researchers at the Moores Cancer Center at the University of California, San Diego report that they have developed a new method for detecting cancer very early in its development, when it consists of just a few cells. (Wed, 18 Apr 2007 07:03:39 GMT)
Millennium Discovers Biomarkers Potentially Predictive Of Response To VELCADE(R) (Bortezomib) For Injection
Findings published in the April 15th issue of Blood show that a team of researchers led by Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) has discovered biomarkers which may lead to identifying multiple myeloma patients likely to respond to VELCADE. VELCADE is the U.S. market leading therapy for previously treated multiple myeloma patients with an unsurpassed median survival of 29. [click link ... (Wed, 18 Apr 2007 07:05:23 GMT)
AVN944 Biomarker Study Identifies Gene Signatures Important For Patient Stratification
Avalon Pharmaceuticals, Inc. (Nasdaq: AVRX), today announced the results of an AVN944 biomarker study that utilized Avalon's proprietary AvalonRx(R) technology to identify gene signatures that may be useful for patient stratification. [click link for full article] (Wed, 18 Apr 2007 07:06:04 GMT)
Macaque Genome Analysis Will Help Find Human Disease Genes
Cornell experts in computational biology and bioinformatics have made key contributions to the analysis of the genome of the rhesus macaque, better known as the rhesus monkey. The Cornell researchers were part of a consortium of some 200 scientists around the world whose work is reported in a special section of the journal Science. [click link for full article] (Wed, 18 Apr 2007 08:04:14 GMT)
aTyr Pharma Completes $10.5M Series B Round
SAN DIEGO----aTyr Pharma, a privately held biopharmaceutical company focused on identifying and developing a novel class of naturally occurring protein biologics for human therapeutics, today announced the closing of its $10.5 million Series B financing. (Wed, 18 Apr 2007 10:00:00 GMT)
H5N1 western genomes sequenced
In a paper in the May issue of Emerging Infectious Diseases , an international team of researchers report the first ever large-scale sequencing of western genomes of the deadly avian influenza virus, H5N1. (Wed, 18 Apr 2007 11:34:46 GMT)
Affymetrix to Host Conference Call on April 25, 2007 to Announce First Quarter 2007 Results
SANTA CLARA, Calif.----Affymetrix, Inc. today announced that it will release results for the first quarter 2007 after close of the stock market on Wednesday, April 25, 2007. (Wed, 18 Apr 2007 12:00:00 GMT)
Molecular Biometrics to Open Research and Development Facility in Montreal
Molecular Biometrics, LLC, a privately held metabolomics company, today announced the opening of a research and development facility in Montreal, Quebec. Molecular Biometrics Canada, ULC, will operate and manage the facility. (Wed, 18 Apr 2007 12:05:00 GMT)
Case Studies of Over 100 Non-Biotechnology/Non-Pharmaceutical Companies
DUBLIN, Ireland----Research and Markets has announced the addition of "Comprehensive Analysis of R&D and Commercialization for Related Biotechnologies from Non-Biotechnology/Non-Pharmace Companies" to their offering. (Wed, 18 Apr 2007 12:20:00 GMT)
Biosite Incorporated Receives Revised Commitment Letters From Inverness Medical Regarding Possible Merger Transaction
Biosite Incorporated today announced that Inverness Medical Innovations, Inc. has provided Biosite with copies of revised commitment letters from Inverness' proposed financing sources in connection with the previously announced acquisition proposal made by Inverness to acquire all of Biosite's outstanding shares of common stock, other than Biosite shares already owned by Inverness, for $90.00 ... (Wed, 18 Apr 2007 12:30:00 GMT)
Biomarkers Influence on Drug Discovery and Clinical Diagnostics Continues to Expand
Biomarkers are being incorporated into several stages of drug discovery and development as they bear the potential to accelerate preclinical and clinical development. Furthermore, theranostic applications have penetrated the market, paving the way for the integration of biomarker applications in the diagnostics and pharmaceutical industry. (Wed, 18 Apr 2007 12:30:00 GMT)
Biosite Incorporated Receives Revised Commitment Letters From Inverness Medical Regarding Possible Merger Transaction
SAN DIEGO, April 18 /PRNewswire-FirstCall/ -- Biosite Incorporated ( Nachrichten ) today announced that Inverness Medical Innovations, ( Nachrichten ) Inc. has provided Biosite with copies of revised commitment letters from Inverness' proposed financing sources in connection with the previously announced acquisition proposal made by Inverness to acquire all of Biosite's outstanding shares of ... (Wed, 18 Apr 2007 12:38:22 GMT)
'We introduced Kannapolis to the world'
Researchers wind up two-day conference; Murdock goes forward with N.C. Research Campus CHARLOTTE — Visiting scientists offered some advice Tuesday for charting the future of the North Carolina Research Campus in Kannapolis. (Wed, 18 Apr 2007 12:40:40 GMT)
Lumera Launches Podcast Series Featuring Experts in Nanotechnology, Bio-Arrays, Electro-Optics and Wireless Technologies
BOTHELL, Wash.----Lumera Corporation , a leader in the emerging field of nanotechnology, announced today it would host a series of podcast interviews with industry leaders who are familiar with Lumera's technology and are experts in nanotechnology, bio-arrays, drug discovery, electro-optics, and wireless technologies. (Wed, 18 Apr 2007 13:00:00 GMT)
Red Hat Teams with UNC and the North Carolina Research Campus to Bring Open Source Philosophy to Campus
RALEIGH, N.C.----Red Hat, Inc. , the world's leading provider of open source solutions, today announced that the company would work with the University of North Carolina system and the North Carolina Research Campus to advance the adoption of open source philosophies of standards and collaboration in biotechnology, bioinformatics, public policy and healthcare research. (Wed, 18 Apr 2007 13:30:00 GMT)
Thallion Presents Data at the 2007 Annual Meeting of the American Association of Cancer Research on its Oncology Drug ...
MONTREAL, QUEBEC-- - Thallion Pharmaceuticals Inc. today announced that new data on its two anticancer drug candidates, ECO-4601 and CAP-232, have been presented in three poster presentations at the 98th Annual Meeting of the American Association for Cancer Research , held in Los Angeles April 14-19, 2007. (Wed, 18 Apr 2007 13:45:23 GMT)
Medica Supports Minnesota Partnership
MINNETONKA, Minn.----Medica, through its grant-making arm the Medica Foundation, has awarded $5 million to the Minnesota Partnership for Biotechnology and Medical Genomics to support three research projects in cancer and heart disease, as well as two projects to provide critical research infrastructure improvements. (Wed, 18 Apr 2007 14:11:00 GMT)
Red Hat to Open Office at N.C. Research Campus
Raleigh — Red Hat will open an office at the North Carolina Research Campus as part of its efforts to expand use of open source solutions in biotech and life science research. (Wed, 18 Apr 2007 14:19:34 GMT)
A Positive Prognosis for Pharmaceuticals
S&P says the group's stock-price momentum—and solid fundamentals—add up to a healthy future (Wed, 18 Apr 2007 14:34:48 GMT)
Agilent Technologies Awards Microarray Prize To Dutch Scientist For Research On Tumor Suppressor Genes
Agilent Technologies Inc. announced that Klaas Kok, Ph.D., of the Department of Genetics, University Medical Center Groningen in the Netherlands, has won 50 free microarrays in the Agilent Technologies Microarray Contest on the basis of his innovative research (Wed, 18 Apr 2007 15:02:02 GMT)
Red Hat to occupy site at N.C. Research Campus
Software company Red Hat Inc. will establish a satellite office at the N.C. Research Campus in Kannapolis. (Wed, 18 Apr 2007 15:11:47 GMT)
Red Hat signs up for N.C. Research Campus in Kannapolis
Raleigh software company Red Hat Inc. will establish a satellite office at the North Carolian Research Campus in Kannapolis. (Wed, 18 Apr 2007 15:38:19 GMT)
Viventia Biotech generates novel human anti-cancer antibody, VB1-050, and identifies its novel target
Viventia Biotech Inc., a privately held biopharmaceutical company advancing a portfolio of novel antibody products focused on cancer, today announced that it has generated a novel, fully human anti-cancer antibody, VB1-050, and also identified the novel target for the antibody, a mutant form of the protein Glut-8. (Wed, 18 Apr 2007 15:42:00 GMT)
Medica provides $5M research grant
Medica announced Tuesday that it has awarded $5 million in research-grant funding to the Minnesota Partnership for Biotechnology and Medical Genomics. (Wed, 18 Apr 2007 16:20:45 GMT)
Common algae helps illustrate mammalian brain electrical circuitry
DURHAM, N.C. -- Mice whose brain cells respond to a flash of light are providing insight into the complexities of the sense of smell and may ultimately yield a better understanding of how the human brain works. (Wed, 18 Apr 2007 16:22:57 GMT)
Red Hat to set up Kannapolis office
The company, the worlds largest distributor of the open-source Linux operating system, announced this morning it will open an office on the N.C. Research Campus in Kannapolis and lead other tenants in applying open-source approaches to their research. (Wed, 18 Apr 2007 16:32:54 GMT)
Luminex Corporation First Quarter Earnings Release Scheduled for May 2, 2007
Luminex Corporation today announced that it expects to report first quarter results on Wednesday, May 2, 2007. (Wed, 18 Apr 2007 17:00:00 GMT)
Red Hat tries spreading open-source idea
Blog: Red Hat is taking a second crack at trying to spread its open-source philosophy beyond the realm of software development.On Wednesday,... (Wed, 18 Apr 2007 17:05:49 GMT)
Power3 Medical Delays Filing 2006 Form 10-KSB
HOUSTON----Power3 Medical Products, Inc. said today that it will file Form 8-K with the Securities and Exchange Commission tomorrow, reporting that it was unable to file its 2006 Form 10-KSB within the extended filing deadline ending today, but that it expects to file the 10-KSB within 30 days. (Wed, 18 Apr 2007 17:46:00 GMT)
Researchers identify key gene that may be a marker of breast cancer metastasis
Researchers at Fox Chase Cancer Center have identified an important gene involved in the spread of breast cancer that has developed resistance to long-term estrogen deprivation. (Wed, 18 Apr 2007 18:25:12 GMT)
VC Spending on -omics Shops Slides 25 Percent in Q1, But Proteomics, Genomics Grows
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Wed, 18 Apr 2007 18:44:17 GMT)
Medica Supports Minnesota Partnership
Medica, through its grant-making arm the Medica (Wed, 18 Apr 2007 19:02:37 GMT)
Tristar Technology Enables Gene Finding That Could Lead To Personalized Treatment For Breast Cancer
Rockville, MD-based TriStar Technology Group (TriStar) today announced results of a genetic study could have major implications in the treatment of breast cancer. [click link for full article] (Wed, 18 Apr 2007 19:07:23 GMT)
A Positive Prognosis for Pharmaceuticals
During the past month, the S&P 1500 Pharmaceuticals subindustry index saw its relative strength ranking rise to 4 from 3, indicating that its trailing 12-month price performance advanced into the top 30% of all 136 subindustries in this composite benchmark (which consists of the S&P 500, MidCap 400, and SmallCap 600 indexes), as compared with the middle 40% only three months ago. (Wed, 18 Apr 2007 19:11:21 GMT)
Cancer Biomarkers Could Help Guide Treatment
WEDNESDAY, April 18 (HealthDay News) -- New biomarkers could help doctors predict how individual cancer patients will respond to drug or radiation therapy, new research suggests, (Wed, 18 Apr 2007 20:02:09 GMT)
Avalon Pharmaceuticals announces results of AVN944 biomarker study
Avalon Pharmaceuticals has announced the results of an AVN944 biomarker study that utilized Avalon's proprietary AvalonRx technology to identify gene signatures that may be useful for patient stratification. (Wed, 18 Apr 2007 20:49:21 GMT)
Power3 Medical Delays Filing 2006 Form 10-KSB
Power3 Medical Products, Inc. (OTC: PWRM) said (Wed, 18 Apr 2007 22:03:53 GMT)
Company roundup
NEW BUSINESS Medica, Minnetonka, through its grantmaking arm, the Medica Foundation, has awarded $5 million to the Minnesota Partnership for Biotechnology and Medical Genomics to support three research projects in cancer and heart disease, as well as two projects to provide critical research infrastructure improvements. PERFORMANCE Northern Tool + Equipment Co., Burnsville, a supplier of tools, ... (Thu, 19 Apr 2007 00:34:44 GMT)
Canberra, ACT, Australia April 19, 2007 Wheat and barley that can cope with extreme environmental conditions, including ...
(ACPFG). The Minister for Education, Science and Training, the Hon Julie Bishop MP, and Parliamentary Secretary to the Minister for Agriculture, Fisheries and Forestry, the Hon Sussan Ley MP, today announced an additional investment of $21 million over five years in the ACPFG. (Thu, 19 Apr 2007 01:54:29 GMT)
Bird Flu Genome Study Shows New Strains, Western Spread
A recent study shows three distinct, independently evolving lineages of Avian Flu. The broad dispersal of the different forms of the virus throughout several different countries over a relatively short period of time points to the possibility of human movement, rather than wild birds as the reason for the quick spread of the H5N1. (Thu, 19 Apr 2007 02:06:27 GMT)
Back to Beantown: Genstruct Buys Incellico Assets
RESEARCH TRIANGLE PARK — Editor's note: RTP Beat is a regular feature on Thursdays. Bioinformatics software provider Incellico has returned to its roots. Originally founded in Boston in 2000, the company moved to Research Triangle later that year. (Thu, 19 Apr 2007 06:04:43 GMT)
Registrations
Baxter YMCA: 7900 Shelby St. (317) 881-9347. Baxter YMCA Sports Camp Registration: Continues through May 31 for weekly camps June 4-Aug. 10. Children 6-11 can choose from aquatics, baseball, cheerleading, dodge ball, flag football, gymnastics, kickball, martial arts, racquetball, soccer, sports spectacular, volleyball and wall ball camps. (Thu, 19 Apr 2007 07:43:10 GMT)
Red Hat to set up in Kannapolis
Red Hat will be one of the first corporate partners at the new N.C. Research Campus, a $1.5 billion academic-business project under construction in this once-booming textile town. (Thu, 19 Apr 2007 07:46:47 GMT)
Learn About the Specific Segments of the Global Gene Expression Reagents Market
LYON, France----Reportlinker.com announces that a new market research report related to the worldwide gene reagents industry is now available to its catalogue. (Thu, 19 Apr 2007 08:48:00 GMT)
Acacia Research to Release First Quarter Financial Results and Host Conference Call
NEWPORT BEACH, Calif.----Acacia Research Corporation announced today it will release its first quarter financial results on Thursday, April 26, 2007. Results will be released at the close of trading on the NASDAQ national market. (Thu, 19 Apr 2007 10:00:00 GMT)
Acacia Technologies Acquires Rights to Patents for Electronic Message Advertising
NEWPORT BEACH, Calif., BUSINESS WIRE -- Acacia Research Corporation (Nasdaq:ACTG)(Nasdaq:CBMX) announced today that Acacia Patent Acquisition Corporation, a wholly owned subsidiary that is part of the Acacia Technologies group, a leader in technology licensing, has acquired rights to patents relating to electronic message advertising. (Thu, 19 Apr 2007 11:23:30 GMT)
Robot, Yeast Combo May Mean More Ethanol
Scientists with the Agricultural Research Service ( ARS ) in Peoria, Ill., are excited about the latest member to join their team: a one-armed robot. They expect it to speed studies aimed at harnessing the power of proteins for industrial uses, such as making fuel ethanol from fibrous corn stover. (Thu, 19 Apr 2007 11:38:08 GMT)
QuantRx(R) Biomedical Acquires Majority Interest in FluoroPharma
QuantRx® Biomedical Corporation, an emerging leader in the development and commercialization of medical diagnostic platforms and products, today announced that it has increased its holdings in FluoroPharma, Inc., a Boston-based molecular imaging company, to a controlling interest. (Thu, 19 Apr 2007 12:27:00 GMT)
Power3 Medical Able to Offer Blood-Based Tests for Detection of Breast Cancer and Neurodegenerative Diseases after ...
HOUSTON----Power3 Medical Products, Inc. , a leading proteomics company specializing in the development and commercialization of early detection diagnostic tests for neurodegenerative disease and breast cancer, announced today that it has received a certification to begin offering CLIA-compliant high complexity medical testing services. (Thu, 19 Apr 2007 12:29:00 GMT)
New Review Examines the Markets for Gene Expression Reagents and Small Lab Equipment All the Way up to Highly Automated ...
DUBLIN, Ireland----Research and Markets has announced the addition of Gene Expression Reagents Markets to their offering. (Thu, 19 Apr 2007 13:00:00 GMT)
Insurance company money awarded to research projects
For the first time, the Minnesota Partnership for Bioscience and Medical Genomics has awarded money from a private company to partnership research projects. The projects (Thu, 19 Apr 2007 13:25:25 GMT)
Ceremony heralds construction milestone for UNC-Chapel Hill's Nutrition Research Institute
KANNAPOLIS — The stage held more than 40 people, who seemingly stretched the width of the monstrous shell of a building behind them. Most of the dignitaries already had signed the beam that a crane would lift skyward and set down as the final piece of steel. (Thu, 19 Apr 2007 13:40:30 GMT)
Robot, Yeast Combo May Mean More Ethanol
Scientists with the Agricultural Research Service (ARS) in Peoria , Ill. , are excited about the latest member to join their team: a one-armed robot. They expect it to speed studies aimed at harnessing the power of proteins for industrial uses, such as making fuel ethanol from fibrous corn stover. (Thu, 19 Apr 2007 13:53:10 GMT)
Power3 Medical Able to Offer Blood-Based Tests for Detection of Breast Cancer and Neurodegenerative Diseases After ...
Power3 Medical Products, Inc. (OTC: PWRM, www.P (Thu, 19 Apr 2007 15:02:15 GMT)
What are your favorite places on campus?
The University at Buffalo is looking for some new angles on its campuses—literally. Starting today, the university is launching Framing UB, a year-long photo and video contest for students, faculty and staff. (Thu, 19 Apr 2007 16:06:15 GMT)
Breaking news: Johnson & Johnson to expand
Johnson & Johnson to expand Springhouse facility by 150,000 square feet for new labs and other needs. (Thu, 19 Apr 2007 18:05:45 GMT)
Cancer Biomarkers Could Help Guide Treatment
Title: Cancer Biomarkers Could Help Guide Treatment Category: Health News Created: 4/19/2007 2:00:00 AM Last Editorial Review: 4/19/2007 (Thu, 19 Apr 2007 19:29:16 GMT)
Invitrogen to Present at the Robert W. Baird 2007 Growth Stock Conference
CARLSBAD, Calif.----Invitrogen Corporation announced today that Gregory T. Lucier, Invitrogen's Chairman and Chief Executive Officer, will present at Robert W. Baird's 2007 Growth Stock Conference being held at the Four Seasons Hotel in Chicago, Illinois. (Thu, 19 Apr 2007 20:37:00 GMT)
TCS signs MoU with State Government on SEZ
A development centre to be set up in Ibrahimpatnam mandal of RR district (Thu, 19 Apr 2007 21:41:40 GMT)
Dundee Cell Products to expand after six-figure cash injection
DUNDEE Cell Products, one of the city's thriving community of life-sciences hopefuls, is set to expand after a six-figure cash injection from the Discovery Investment Fund angel syndicate. (Thu, 19 Apr 2007 23:21:54 GMT)
Robot, Yeast Combo May Mean More Ethanol
Scientists with the Agricultural Research Service, are excited about the latest member to join their team: a one-armed robot. They expect it to speed studies aimed at harnessing the power of proteins for industrial uses, such as making fuel ethanol from fibrous corn stover. (Fri, 20 Apr 2007 01:06:26 GMT)
Scientist to discuss evolutionary biology
LAS CRUCES — Mary Jane West-Eberhard, a senior scientist at the Smithsonian Tropical Research Institute, will present a public lecture, "Development and Evolution: a Darwinian Renaissance in Biology," at 4 p.m. today in New Mexico State University's Hardman Hall, Room 208. (Fri, 20 Apr 2007 01:13:04 GMT)
Red Hat Project Promotes Open Source for Clinical Research
Open source software vendor Red Hat is teaming up with North Carolina research and education establishments in an attempt to encourage the adoption of open source development policies in other areas. (Fri, 20 Apr 2007 06:06:58 GMT)
Teachers get course on bugs, CSI in class
Teachers from across Arizona are headed back to school to attend workshops on topics ranging from teenage romance to insects. (Fri, 20 Apr 2007 08:41:17 GMT)
Enigma Diagnostics Appoints Dr Lynn Busteed as Chief Executive Officer
Enigma Diagnostics, the life sciences company developing rapid molecular diagnostics systems, announces today the appointment of Dr Lynn Busteed as Chief Executive Officer and a member of the Board of Directors. (Fri, 20 Apr 2007 08:59:00 GMT)
Red Hat project promotes open source for clinical research
Open source software vendor Red Hat is teaming up with North Carolina research and education establishments in an attempt to encourage the adoption of open source development policies in other areas. (Fri, 20 Apr 2007 10:28:30 GMT)
Red Hat to Team With Universities on $1.5B Healthcare Project
Red Hat will be one of the first corporate partners at the new North Carolina Research Campus, a $1.5 billion academic-business project under construction in the once-booming textile town of Kannapolis, N.C. Establishing a satellite office at the campus will allow the Raleigh, N.C., company to apply its open source software and philosophy to the biotechnology, bioinformatics, public policy and ... (Fri, 20 Apr 2007 11:10:16 GMT)
SAS to Host Consortium Studying Genomics for Drug Research
Researchers participating in a federally funded study exploring use of DNA technology in drug development will gather at SAS for a conference on May 24-25. (Fri, 20 Apr 2007 11:34:33 GMT)
Biosite Incorporated Receives Further Revised Commitment Letters From Inverness Medical Regarding Possible Merger ...
Biosite Incorporated today announced that, on April 19, 2007, Inverness Medical Innovations, Inc. provided Biosite with copies of further revised commitment letters from Inverness' proposed financing sources in connection with the previously announced acquisition proposal made by Inverness to acquire all of Biosite's outstanding shares of common stock, other than Biosite shares already owned by ... (Fri, 20 Apr 2007 12:30:00 GMT)
Rosetta Genomics Announces it has Presented Data on Advancements Made in the Company's Lead Assay Development Program ...
Rosetta Genomics, Ltd. , announced today that it has presented updated results on its lead diagnostic development program for cancer of unknown primary , at the Annual Meeting of the American Association for Cancer Research , in Los Angeles, California. (Fri, 20 Apr 2007 12:47:00 GMT)
Viventia Biotech Generates Novel Human Anti-Cancer Antibody, VB1-050, And Identifies Its Novel Target
Viventia Biotech Inc., a privately held biopharmaceutical company advancing a portfolio of novel antibody products focused on cancer, today announced that it has generated a novel, fully human anti-cancer antibody, VB1-050, and also identified the novel target for the antibody, a mutant form of the protein Glut-8 (Fri, 20 Apr 2007 14:02:04 GMT)
Early Drug Discovery Expected To Improve With First-Of-Its-Kind Mass Spectrometry Platform From Applied Biosystems/MDS ...
Applied Biosystems, an Applera Corporation business, and its joint venture partner, Sciex, a division of MDS Inc.'s Analytical Technologies business, today announced plans to commercialize a first-of-its-kind mass spectrometry platform designed to help pharmaceutical companies accelerate the drug compound screening process (Fri, 20 Apr 2007 14:02:24 GMT)
Robot, yeast combo may mean more ethanol
UNITED STATES: Robot system operates much faster than humans. Scientists with the Agricultural Research Service (ARS) in Peoria, Illinois, expect a new one-arm robot to speed studies aimed at harnessing the power of proteins for industrial uses, such as making fuel ethanol from fibrous corn stover. (Fri, 20 Apr 2007 14:10:42 GMT)
Development of Disposable Polymer Smart LOCs Opens New Era for Point-of-care Testing
DUBLIN, Ireland----Research and Markets has announced the addition of the Frost & Sullivan report: Advances in Lab-on-Chip and Microfluidics Technologies for Drug Discovery and Clinical Diagnostics to their offering. (Fri, 20 Apr 2007 17:00:00 GMT)
Downtown medical school given $5M grant
The University of Arizona Foundation received $5 million from the Virginia G. Piper Charitable Trust to benefit the UA's new medical school in downtown Phoenix. (Fri, 20 Apr 2007 17:42:39 GMT)
$5M gift said vital to hiring faculty for UA's Medicine-Phoenix
A $5 million gift to the University of Arizona College of Medicine-Phoenix will aid in recruiting faculty for the emerging campus, the school announced today. (Fri, 20 Apr 2007 18:33:08 GMT)
Researchers Report Ability to Detect Cancer at Earliest, Curable Stage
Researchers at the Moores Cancer Center at the University of California, San Diego report that they have developed a new method for detecting cancer very early in its development, when it consists of just a few cells. The best existing detection methods are not able to detect a tumor until it consists of about one million cells. (Fri, 20 Apr 2007 19:48:58 GMT)
News tips from the Journal of Biological Chemistry
This article was featured as a "Paper of the Week" by the Journal of Biological Chemistry’s Editors, meaning that it belongs to the top one percent of papers reviewed in significance and overall importance. (Fri, 20 Apr 2007 20:55:12 GMT)
Norway Will Spend $70M to Spur Functional Genomics Research; Start-Ups Particularly Welcome
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Fri, 20 Apr 2007 23:59:17 GMT)
Scientists develop novel computer-aided drug design
Scientists Dr M. Rami Reddy and Dr Mark Erion, in consultation with Dr U Chandra Singh have developed computer-assisted drug design (CADD) approaches for the discovery of potential novel drugs for type-2 diabetes. (Sat, 21 Apr 2007 03:19:42 GMT)
$5M gift to UA Foundation to benefit new med college
The University of Arizona Foundation received a $5 million gift on Friday to benefit the new UA College of Medicine in Phoenix. (Sat, 21 Apr 2007 07:21:03 GMT)
Scottsdale Charros name Outstanding Student and Educator winners
The Scottsdale Charros named Rachel Baumann and Bianca Haase, Outstanding Students of the Year for the Scottsdale Unified School District. (Sat, 21 Apr 2007 20:41:15 GMT)
An Important New Clue In Susceptibility To Crohn's Disease
Crohn's disease is a chronic relapsing inflammatory disorder of the intestinal tract that affects an estimated 0.15% of people in the developed world. Common symptoms include abdominal pain and diarrhea, but the disorder is often associated with debilitating clinical complications. [click link for full article] (Sat, 21 Apr 2007 23:04:21 GMT)
Scientists Discover New Virus Responsible for Deaths of 3 Transplant Recipients From Single Donor in Victoria, Australia
Scientists in the Greene Infectious Disease Laboratory of the Columbia University Mailman School of Public Health and colleagues in the Victorian Infectious Diseases Reference Laboratory in Melbourne, Australia and 454 Life Sciences have discovered a new virus that was responsible for the deaths of three transplant recipients who received organs from a single donor in Victoria, Australia. (Sun, 22 Apr 2007 01:00:00 GMT)
A special doctor gets some special support
Mike Fox was an infant when Dr. Holmes Morton found the inspiration for what would become his life's work among the Plain communities in Lancaster County. Fox, now a senior at Franklin & Marshall College, has inherited a strain of that inspiration and plans to be a pediatrician like Mor... (Sun, 22 Apr 2007 03:13:17 GMT)
PUBLIC COMPANY NEWS
Aetrium (Nasdaq: ATRM): Reported first-quarter net income of $544,000 and revenue of $5.1 million, compared with net income of $476,000 and revenue of $6.9 million for the year-earlier quarter. (Sun, 22 Apr 2007 05:23:30 GMT)
St. Jude's caters to kids
This is the first of a two-part look at the mission of St. Jude Children's Research Hospital in Memphis; part two in the series will appear in Sunday's Daily News. (Sun, 22 Apr 2007 05:45:19 GMT)
Education Beat
(Sun, 22 Apr 2007 07:34:54 GMT)
1 of life's most common compounds causes allergic inflammation
The beetle's back and the crab's shell owe their toughness to a common compound called chitin that now appears to trigger airway inflammation and possibly asthma, UCSF scientists have found. (Sun, 22 Apr 2007 17:23:07 GMT)
Crab Shell, Insect Exoskeleton And Other Forms Of Chitin Cause Allergic Inflammation
The beetle's back and the crab's shell owe their toughness to a common compound called chitin that now appears to trigger airway inflammation and possibly asthma, scientists have found. (Sun, 22 Apr 2007 19:06:46 GMT)
The Top Drawer
Ornate and custom-designed or salvaged from an old office, barren as a flat sea or piled high with folders and photographs, the desk is the businessperson's home for much of the day. It is not only a tool but also a symbol, and it can reveal much about the person who occupies it. (Mon, 23 Apr 2007 03:49:58 GMT)
The Faithful Spy: Amerithrax Spoiler Alert
New York Times correspondent Alex Berenson has written a spy thriller called Faithful Spy. The hero, John Wells, has been undercover so long that the CIA is no longer sure where his loyalties lie. Only the mid-level CIA analyst at Langley, Jennifer Exley, believes in him. (Mon, 23 Apr 2007 08:53:24 GMT)
CombiMatrix Updates Influenza-Detection System and Demonstrates Use
NEWPORT BEACH, Calif.----Acacia Research Corporation announced today that its CombiMatrix group has updated its Influenza-Detection System, which consists of the CombiMatrix Influenza A Microarray, ElectraSense reader, and sample-preparation kit. (Mon, 23 Apr 2007 09:59:00 GMT)
Bio-Rad Laboratories wins 3 life science awards of The Scientist
Bio-Rad Laboratories has bagged three awards, which were instituted by the international life sciences magazine The Scientist, in the product categories of image analysis systems, instrumentation for protein analysis and protein separation products. (Mon, 23 Apr 2007 10:49:02 GMT)
Red Hat Project Promotes Open Source for Clinical Research
Open source software vendor Red Hat is teaming up with North Carolina research and education establishments in an attempt to encourage the adoption of open source development policies in other areas. (Mon, 23 Apr 2007 10:57:27 GMT)
Applied Biosystems/MDS SCIEX Announces New Proteomics Tools for Biomarker Research
FOSTER CITY, Calif.----Applied Biosystems , an Applera Corporation business, and its joint venture partner, Sciex, a division of MDS Inc.'s Analytical Technologies business, , today announced a new instrument system and software designed to assist the growing number of life scientists involved in biomarker research. (Mon, 23 Apr 2007 11:00:00 GMT)
Acacia Technologies Acquires Rights to Patent for Physical Access Control
NEWPORT BEACH, Calif., BUSINESS WIRE -- Acacia Research Corporation (Nasdaq:ACTG)(Nasdaq:CBMX) announced today that Acacia Patent Acquisition Corporation, a wholly owned subsidiary that is part of the Acacia Technologies group, a leader in technology licensing, has acquired rights to a patent relating to physical access control. (Mon, 23 Apr 2007 11:23:20 GMT)
Reminder - Biosite to Conduct First Quarter 2007 Results Conference Call
Biosite Incorporated announces the following webcast: (Mon, 23 Apr 2007 11:45:00 GMT)
Affymetrix Clinical Services Laboratory Receives CLIA Certification
SANTA CLARA, Calif.----Affymetrix Inc. today announced that the Affymetrix Clinical Services Laboratory successfully passed the State of California survey for CLIA certification on April 9, 2007. (Mon, 23 Apr 2007 12:00:00 GMT)
Terra Soft CEO Kai Staats: Rallying Around the Cell Processor and Power Architecture
Kai Staats, CEO of Yellow Dog Linux developer Terra Soft and founder of the HPC Consortium, presented a key address on "The Business Case For Software on Power" and an overview of the consortium and that organization's first Hack-a-thon held in January. LinuxInsider discussed with Staats the issues involving Power Architecture, the HPC Consortium and open source technology. (Mon, 23 Apr 2007 12:04:46 GMT)
NYU Medical Center Partners With Rosetta Genomics to Develop a Line of Diagnostic Tools for Lung and Mesothelioma ...
Rosetta Genomics, Ltd. announced today that it has partnered with NYU Medical Center with the aim of developing a line of early detection diagnostic products for lung, and Mesothelioma cancers. (Mon, 23 Apr 2007 12:30:00 GMT)
CombiMatrix Updates Influenza-Detection System and Demonstrates Use
Acacia Research Corporation (Nasdaq:CBMX) (Nasdaq:ACTG) announced today that its CombiMatrix group has updated its Influenza-Detection System, which consists of the CombiMatrix Influenza A Microarray, ElectraSense™ reader, and sample-preparation kit. (Mon, 23 Apr 2007 13:03:17 GMT)
NYU, Rosetta Genomics to Co-develop miRNA-based Lung Cancer Test
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Mon, 23 Apr 2007 13:59:27 GMT)
New Information About Old Proteins Offers Researchers Shortcuts To Study Disease
Researchers at Johns Hopkins took advantage of a new technique that reads the makeup of proteins to identify nearly all chemical changes nature makes by adding phosphate to proteins manufactured in human cells. (Mon, 23 Apr 2007 14:06:44 GMT)
One of life's most common compounds causes allergic inflammation
The beetle`s back and the crab`s shell owe their toughness to a common compound called chitin that now appears to trigger airway inflammation and possibly asthma, UCSF scientists have found. (Mon, 23 Apr 2007 14:33:57 GMT)
Investing in Rosetta Genomics Means Investing in MiRNAs
Brian Orelli submits: The best thing that Rosetta Genomics has going for it is that it has a huge amount of intellectual property. It has patents on hundreds of miRNAs. Essentially, at this point, an investment in Rosetta Genomics is an investment in miRNAs. (Mon, 23 Apr 2007 14:49:51 GMT)
ots: Genopole: Two-Week Seasonal School on "Biological Complexity ...
Börsennachrichten und aktuelle Meldungen aus Wirtschaft und Finanzen. Marktberichte und News zu Investmentbanking und Fonds - Börsennachrichten bei Stock World. (Mon, 23 Apr 2007 15:15:55 GMT)
Genopole: Two-Week Seasonal School on "Biological Complexity and Modeling"
ÉVRY, France, April 23 (ots/PRNewswire) - April 30 - May 11, 2007 Epigenomics Project, Genopole(R), ÉVRY, France (near Paris) ÉVRY, France, April 23 /PRNewswire/ ... (Mon, 23 Apr 2007 15:20:16 GMT)
Genopole: Two-Week Seasonal School on "Biological Complexity and Modeling"
Genopole(R) and the Epigenomics Project organise a two-week school on biological complexity and modeling in the context of genomics, in Evry, near Paris. (Mon, 23 Apr 2007 15:36:15 GMT)
Scientists discover new virus caused deaths of transplant recipients from single donor
Scientists in the Greene Infectious Disease Laboratory of the Columbia University Mailman School of Public Health and colleagues in the Victorian Infectious Diseases Reference Laboratory in Melbourne, Australia and 454 Life Sciences have discovered a new virus that was responsible for the deaths of three transplant recipients who received organs from a single donor in Victoria, Australia. (Mon, 23 Apr 2007 15:38:07 GMT)
Scientists Discover New Virus Caused Deaths Of Transplant Recipients From Single Donor
Scientists have discovered a new virus that was responsible for the deaths of three transplant recipients who received organs from a single donor in Australia. (Mon, 23 Apr 2007 16:07:06 GMT)
New virus discovered
WHAT: The unfortunate deaths of three organ transplant recipients in Australia this past January has led to the discovery of a new virus. (Mon, 23 Apr 2007 16:53:07 GMT)
Liepmann joins Stinson Morrison Hecker firm
Karen Liepmann joined Stinson Morrison Hecker as partner in the general business division in Phoenix. She has 20 years' experience in general business and tribal corporate law as well as technology, franchise and intellectual-property law. (Mon, 23 Apr 2007 17:12:08 GMT)
Public, private sector tout region
The late summer "Explore Buffalo Niagara 2007" conference hopes to go where no other economic development effort has gone before. (Mon, 23 Apr 2007 18:29:34 GMT)
Duke in the News: April 23, 2007
OP-ED: CHALLENGE OF PREVENTING VIOLENCE IS NOT JUST AN AMERICAN PROBLEM (London) The Guardian, April 22 -- Jeffrey Swanson, a sociologist and associate professor at the Duke University School of Medicine, writing with a colleague at the University of Virginia, says the "scientific challenges of predicting violence, and the legal challenges of preventing it, transcend national borders." (Mon, 23 Apr 2007 19:45:05 GMT)
Pharmacom: I.C. tech firm shows how to be small and global
A huge multimedia data base for the People's Republic of China, energy drinks for golfers in Scandinavia, and biosensors for homeland security in the United States are all linked by technological threads in the mind of Iowa City businessman and researcher William Wang. (Mon, 23 Apr 2007 21:25:20 GMT)
Invitrogen Establishes Technology Networks
CARLSBAD, Calif.----Invitrogen Corporation , a provider of essential life science technologies for disease research and drug discovery, today announced it has launched a program whereby GIBCO® cell culture media products and platforms offered by PD-Direct Bioprocess Services are evaluated in concert with third party technologies. (Mon, 23 Apr 2007 21:48:00 GMT)
Genes And Biomarkers That Allow Doctors To Choose The Right Therapy For The Right Patient
Genetic and epigenetic variations ensure that no two people are exactly alike, and the same holds true for any two cancers. Now, researchers have the tools and the knowledge to help predict how individuals will respond to cancer therapies, enabling them to create more effective therapies for individual cancers - personalized medicine. [click link for full article] (Tue, 24 Apr 2007 02:04:12 GMT)
Previous 1 2 3 4 5 Next
